Related Experiment Video
Updated: Sep 19, 2025

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
1.3K
Explainable AI predicting Alzheimer's disease with latent multimodal deep neural networks.
Xi Chen1, Jeffrey Thompson1, Zijun Yao2
1Department of Biostatistics & Data Science, University of Kansas Medical Center, Kansas City, KS, USA.
Journal of Biopharmaceutical Statistics
|June 18, 2025
Summary
A novel deep learning model accurately predicts Alzheimer's disease (AD) cognitive status using clinical and neuroimaging data. This framework enhances prediction accuracy by incorporating attention mechanisms, highlighting clinical data as the most significant predictor.
Area of Science:
- Neuroscience
- Artificial Intelligence
- Medical Informatics
Background:
- Alzheimer's disease (AD) is a progressive neurodegenerative disorder causing cognitive decline.
- Accurate prediction of AD cognitive status is crucial for timely intervention and management.
Purpose of the Study:
- To develop and evaluate a novel latent multimodal deep learning framework for predicting Alzheimer's disease cognitive status.
- To assess the contribution of clinical, neuroimaging, and genetic data in predicting AD cognitive impairment.
Main Methods:
- Utilized data from 322 patients (aged 55-92) from the ADNI database.
- Applied Confirmatory Factor Analysis (CFA) to derive latent cognitive impairment scores.
- Constructed a multimodal deep neural network with attention and cross-attention layers, integrating clinical, imaging, and genetic data.
Main Results:
- The multimodal neural network incorporating clinical and imaging data with attention layers achieved the best predictive performance (MAE: 0.330, MSE: 0.206).
- Clinical data was identified as the most influential modality, contributing 35% to the prediction of AD cognitive status.
- Attention mechanisms significantly enhanced the model's predictive capabilities.
Conclusions:
- The attention-based multimodal deep learning model demonstrates superior performance in predicting Alzheimer's disease cognitive impairment.
- Integrating multiple data modalities, particularly clinical and neuroimaging data, is effective for AD cognitive status prediction.
- Attention layers are a valuable addition to deep learning models for improving prediction accuracy in neurodegenerative disease research.
Related Concept Videos
Alzheimer's Disease: Overview
686
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
686
Alzheimer's Disease: Treatment
265
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
265

